Single nucleotide polymorphisms in the mannose-binding lectin (MBL2) gene, as well as the serum MBL2 level, have been associated with various autoimmune diseases. We investigated whether such polymorphisms and/or the serum MBL2 level were associated with rheumatoid arthritis (RA) in an Indian population. The frequency of the B variant (codon 54) of the MBL2 gene was quite frequent in the healthy Indian population and was significantly (P=6.35·10 À6 ) lower in RA patients. We replicated this association (P=1.78·10 À5 ) in an independent cohort of control individuals. Promoter polymorphism at À550 nt showed a significant overrepresentation (P=0.003) of the minor allele G in severe RA patients compared with the less severe group. Haplotype LYA frequency was significantly (P=0.03) high in the less severe group, while the frequency of the HYA haplotype was significantly (P=0.04) increased in the severe RA patients. No statistically significant difference in serum MBL2 was observed as a whole, but the individuals homozygous for the LYA haplotype had significantly lower (P=0.017) serum MBL2 levels compared with individuals homozygous for the HYA haplotype. Therefore, the B variant of the MBL2 gene may be associated with protection from RA in our study population, and the promoter polymorphism (À550 nt) seems to have some role in disease progression.
Altered glycosylation of plasma proteins has been directly implicated in the pathogenesis of rheumatoid arthritis (RA). The present study investigated the changes in the Concanavalin-A (Con-A)-bound plasma proteins in the RA patients in comparison to that of the healthy controls. Two proteins (MW approximately 32 kDa and approximately 62 kDa) showed an alteration in expression while an altered monosaccharide profile (high mannose) was observed in the approximately 62 kDa protein in the samples collected from RA patients. The 2-dimensional polyacrylamide gel electrophoresis analysis of the Con-A-bound plasma samples showed a large number of protein spots, a few of which were differentially expressed in the RA patients. Some unidentified proteins were detected in the RA patients which were absent in the control samples. The present study, therefore, enunciates the role of carbohydrates as well as that of the acute phase response in the disease pathogenesis.
We examined the role of tumor necrosis factor (TNF-α) and
its related signaling intermediates leading to
apoptosis/proliferation in the peripheral blood mononuclear cells
(PBMCs) of RA patients. The constitutive expression of mRNA for
TNF-α receptors (TNFR-I and TNFR-II) and the adapter
molecules, such as the TNF receptor-associated death domain
protein (TRADD), Fas-associated death domain protein (FADD),
receptor interacting protein (RIP), and TNF receptor-associated
factor 2 (TRAF-2) were analyzed by reverse transcriptase-PCR
(RT-PCR) in PBMCs from control and RA cases. PBMCs of RA patients
showed a significant increase in TNF-α and TNFR-I expression as compared with that from control subjects along with
significantly increased constitutive expression of TRADD, RIP, and
TRAF-2 mRNA. There was a decrease in expression of FADD in RA
patients, but the difference was not significant as compared to
controls. These data suggested enhanced signaling by the
TNFR-I-TRADD-RIP-TRAF-2 pathway and suppressed signaling by the TNFR-I-TRADD-FADD pathway in PBMCs of
RA patients. However, the regulatory mechanisms for TNF-α induced signaling may not be explained only by these pathways.
Antiphospholipid antibody (APLA) syndrome is a noninflammatory autoimmune disease, with innumerable clinical manifestations ranging from recurrent thrombosis and pregnancy morbidity to valvular lesions, transverse myelitis, thrombocytopenia, and hemolytic anemia. APLAs in antiphospholipid syndrome (APS) are well-known risk factors for cerebrovascular accidents. Stroke is the most common manifestation of APS in the central nervous system. Gingival enlargement is a known side effect of phenytoin which is an antiepileptic drug. This can have a significant effect on the quality of life as well as increasing the oral bacterial load by generating plaque retention sites. The management of gingival overgrowth seems to be directed at controlling gingival inflammation through a good oral hygiene regimen. Thus, this case report aims to describe the conservative management of phenytoin-induced gingival enlargement combined with inflammatory enlargement in a patient with APLA syndrome.
For the replacement of missing teeth, Dental implants have now gained popularity as one of the most significant treatment modality. In an attempt to boost the success rate of this root imitating structure, continuous efforts have been made to modify its materials and designs. To establish healthy osseointegration, biomaterials, designs and surface characteristics of implants play a key role. So, modification in these factors will aid in obtaining long-term implant stability. A wide variety of materials are available in the market and the selection of appropriate implant material is utmost important for accomplishment of successful treatment. Before choosing an implant, the clinicians should have detailed knowledge about the latest implant materials, its design aspects as well as its properties to achieve successful treatment outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.